Call us +91 -7376325889/ 7376335889
Mail
Support
Partners
Careers
Knowledge Center
Downloads
Margin Calculator
Equity
F&O
MF
Online Trading
Open an Account
Back Office
Apply IPO
ABOUT US
SERVICES
MARKETS
Equity
Derivatives
Mutual Fund
IPO
PORTFOLIO
OUR RECOMMENDATIONS
CONTACT US
CALCULATORS
ANNUAL INCOME RANGE
BANK MODIFICATION
MENU
×
HOME
SERVICES
MARKETS
PORTFOLIO
OUR RECOMMENDATIONS
ABOUT US
SERVICES
CONTACT US
CALCULATORS
Online Trading
Open an Account
Back Office
Apply IPO
Equity Analysis
Company Profile
Price
Volume
Analysis
Company Profile
News Analysis
Corporate Action
Other Markets
Detailed Quotes
Detailed Quotes
Company Snapshot
Company Background
Board of Directors
Profit & Loss
Balance Sheet
Quarterly Results
Key Financial Ratios
Share Holding Pattern
Directors Report
Score Board
MF Holdings
Name Change
Company News
Peer Comparison
Monthly High / Low
Price Chart
Consolidated Quarters
FII Holding
Simple & CAGR Growth
Deliverable Volumes
Company Snapshot
Glenmark Pharmaceuticals Ltd
Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value(
)
532296
INE935A01035
848.5800097
NSE Symbol
P/E(TTM)
Mar.Cap(
Cr.)
GLENMARK
22.24
42147.62
EPS(TTM)
Face Value(
)
Div & Yield %:
67.15
1
0.17
BSE
NSE
As on: Feb 06, 2025 02:52 PM
Last Price(
)
Net Change (%)
Volume (Nos)
P / E
1,495.40
1.80
10296
22.24
Chart
|
|
|
|
Stock Price Details
Open Price(
)
1,493.85
Best Buy (
)
1499.2
Best Sell (
)
1500.45
Buy Quantity (Nos)
5
Sell Quantity (Nos)
1
Today's High (
)
1,516.90
Today's Low (
)
1,485.35
52-Week High (
)
1830.05
152-Week Low (
)
766.65
Market Statistics
Div & Yield %
0.17
Eps
67.15
Book Value
848.5800097
Market Cap (
.Cr)
42,147.62
Face Value
1
Market Lot
1
AGM Date
Sep
Book Closure Date
Sep
ISIN No.
INE935A01035
News
Volumes jump at Glenmark Pharmaceuticals Ltd counter
Glenmark Pharmaceuticals to announce Quarterly Result
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Board Meeting
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Trading Window
Barometers pare gains; consumer durables shares tumble
Glenmark Pharmaceuticals launches Phytonadione Injectable Emulsion USP 10 mg/mL
Glenmark Pharma edges higher after US launch of coagulation disorder drug Phytonadione
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Press Release
Glenmark Pharmaceuticals Ltd - Glenmark Pharmaceuticals Limited - Other General Purpose
Glenmark Pharmaceuticals Inc. USA launches Lacosamide Oral Solution
More
Corporate Details
Incoporation Year : 1977
Chairman : Glenn Saldanha
Bussiness Group : Indian Private
Registered Office
Glenmark Pharmaceuticals Ltd
B/2 Mahalaxmi Chambers,
22 Bhulabhai Desai Road,
Mumbai,
Maharashtra-400026
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-22-40189999
Fax:91-22-40189986
Fax:91-22-66317458
E-Mail :
complianceofficer@glenmarkpharma.com
URL :
http://www.glenmarkpharma.com
Exchange Information
Bombay Stock Exchange
National Stock Exchange
Other Listed Exchanges
BSE 500
BSE HC
BSE Midcap
BSE Shariah 50
MIDCAP 200
CNX 500
CNX Pharma
CNX SMALLCA
BSE
Kolkata
Chennai
Ahmedabad
Delhi
Kochi